Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea Source: Eur Respir J 2014; 43: 1097-1105 Year: 2014
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels Source: Eur Respir J 2006; 27: 121-127 Year: 2006
The relationship between obstructive sleep apnea syndrome and apolipoprotein E allels Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
LATE-BREAKING ABSTRACT: Effects of APOE genotype and hypoxia on plasma lipids in obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013
GAD1 polymorphism is associated with obstructive sleep apnea in asthma patients Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Are there genetic influences in obstructive sleep apnea by polymorphisms of the endothelin-receptor-subtype-a-gene? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Apolipoprotein E polymorphisms and incident arterial hypertension in obstructive sleep apnea patients A prospective cohort study Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Total cholesterol and low density lipoprotein (LDL) cholesterol in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 1046-1048 Year: 2012
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Correlation between severity of obstructive sleep apnea (Osa) and serum total cholesterol: Hdl cholesterol (Tc:Hdl) ratio Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010